Psyence Biomedical Statistics Share Statistics Psyence Biomedical has 713.23K
shares outstanding. The number of shares has increased by 0.39%
in one year.
Shares Outstanding 713.23K Shares Change (YoY) 0.39% Shares Change (QoQ) 0.03% Owned by Institutions (%) n/a Shares Floating 713.23K Failed to Deliver (FTD) Shares 516 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 80.52K, so 34.37% of the outstanding
shares have been sold short.
Short Interest 80.52K Short % of Shares Out 34.37% Short % of Float 34.37% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -76.24 and the forward
PE ratio is null.
Psyence Biomedical's PEG ratio is
-0.07.
PE Ratio -76.24 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -355.48 P/FCF Ratio -1321.73 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Psyence Biomedical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.09,
with a Debt / Equity ratio of -0.95.
Current Ratio 0.09 Quick Ratio 0.09 Debt / Equity -0.95 Debt / EBITDA -3.8 Debt / FCF -3.54 Interest Coverage -51.98
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-5.12M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -97.86% in the
last 52 weeks. The beta is 0.18, so Psyence Biomedical's
price volatility has been higher than the market average.
Beta 0.18 52-Week Price Change -97.86% 50-Day Moving Average 4.75 200-Day Moving Average 8.18 Relative Strength Index (RSI) 36.1 Average Volume (20 Days) 1,662,309
Income Statement
Revenue n/a Gross Profit -240 Operating Income -2.75M Net Income -51.16M EBITDA -2.75M EBIT -51.11M Earnings Per Share (EPS) -7.85
Full Income Statement Balance Sheet The company has 762.8K in cash and 10.45M in
debt, giving a net cash position of -9.69M.
Cash & Cash Equivalents 762.8K Total Debt 10.45M Net Cash -9.69M Retained Earnings -57.46M Total Assets 2.25M Working Capital -1.27M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.95M
and capital expenditures -5.73K, giving a free cash flow of -2.95M.
Operating Cash Flow -2.95M Capital Expenditures -5.73K Free Cash Flow -2.95M FCF Per Share -0.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PBM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for PBM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 5, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date May 5, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -36.41 Piotroski F-Score 3
